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Abstract 
Short communication on extraskeletal osteosarcoma 
with data on clinics. 
Identity 
Other names 
Soft tissue osteosarcoma 
Note 
Extraskeletal osteosarcoma is a high-grade 
malignant mesenchymal soft tissue neoplasm 
composed of neoplastic cells (osteoblastic, 
chondroblastic and fibroblastic) that produce 
osteoid, neoplastic bone or chondroid matrix and 
has a clinically aggressive course. For a lesion to be 
defined as extraskeletal osteosarcoma, it must arise 
in the soft tissue and not attached to bone or 
periosteum, have a uniform sarcomatous pattern, 
and produce osteoid and/or cartilage matrix. In 
contrast to the more common osteogenic sarcoma 
(osteosarcoma), extraskeletal osteosarcoma is a rare 
tumor occurring mainly in adults. Often it arises at 
the site of prior radiation therapy. Response to 
treatments (mainly chemotherapy) is worse and 
prognosis is much poorer compared to that for 
primary osteosarcoma of bone. 
Clinics and pathology 
Epidemiology 
Extraskeletal osteosarcoma accounts for 1% to 2% 
of all soft tissue sarcomas and approximately 2% to 
4% of all osteosarcomas. It typically affects patients 
between 50 and 70 years of age. The reported male 
to female ratio is 1.9:1. 
Clinics 
Most extraskeletal osteosarcomas are deep seated; 
<10% are superficial, originating in the dermis or 
subcutis. The most common location is the lower 
extremity (75%; thigh and buttock), followed by the 
upper extremity (15%-23%, shoulder girdle), and 
the retroperitoneum (17%). A progressively 
enlarging soft tissue mass, rarely causing pain or 
tenderness is the most common clinical 
presentation. 
Imaging 
Plain radiographs, CT and MRI usually reveal a 
large deep-seated soft tissue mass with variable 
mineralization. By definition, extraskeletal 
osteosarcomas arise in the soft tissue and are not 
attached to bone or periosteum; however, they may 
secondarily involve the periosteum, cortex or 
medullary canal. 
- Radiography: Shows a mass, possibly with 
peripheral, chunky or linear and mature 
calcification similar to mature bone or heterotopic 
ossification. 
- Computed tomography: Shows a mass with 
ossified rim. The mass is close to the bone but not 
attached to it; a soft tissue mass is interposed 
between the bone and the ossified mass. 
- MR imaging: The unmineralized portion of the 
tumor shows heterogeneous and relatively 
hypointense signal intensity on T1-weighted images 
and hyperintense signal intensity on T2. 
- Scintigraphy: Shows intense accumulation of 
radioactivity in the tumor. 
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Figure 1. Axial T1-weighted (left) and coronal T2-weighted fat suppression (right) MR imaging show a large soft tissue mass in 
the postero-medial thigh. The tumor is not attached to bone. Figure 2. Tumor specimen of an extraskeletal osteosarcoma. 
 
 
- Angiography: May show hypervascularity of the 
tumor. 
Pathology 
Pathogenesis unknown. The majority develops de 
novo; in approximately 10% extraskeletal 
osteosarcomas may be radiation induced. 
Gross pathology: Extraskeletal osteosarcomas may 
grow up to 50 cm (mean, 8-10 cm). 
Macroscopically, the tumors are hemorrhagic and 
focally necrotic, and firmly attached to the fascia 
without attachment to the skeleton; rarely, it may 
lie in contact with the periosteum; >30% appear 
grossly encapsulated, and >10% may exhibit 
extensive haemorrhagic cystic changes. A tough 
connective tissue capsule usually surrounds the  
tumors and adheres to the surrounding structures, 
making dissection difficult. The tumor has a 
remarkable ability to infiltrate the surrounding 
tissues; occasionally it can be confined to the 
subcutis or dermis, or ulcerate the overlying skin. 
Invasion of blood vessels is not common. 
Micro pathology: Extraskeletal osteosarcoma is 
characterized by anaplastic sprindle cell 
proliferation with the presence of osteoid matrix or 
immature bone formed by the neoplastic cells. The 
tumor cells are spindle or polyhedral with 
cytological atypia, malignant chondroid areas, 
extensive areas of necrosis, mitotic activity (>10 
mitoses per 10 high-power fields), and atypical 
mitotic figures. 
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Figure 3. Low power histological sections show calcified bone trabeculae and osteoid elaborated by malignant cells (Stain, 
hematoxylin and eosin; original magnification, 40x). Figure 4. High power histological sections shows pleomorphic malignant 
cells with extracellular matrix production (Stain, hematoxylin and eosin; original magnification, 200x). 
 
All the major subtypes of osteosarcoma of bone 
have been reported in extraskeletal osteosarcoma. 
Common to all variants is the presence of 
neoplastic bone deposited in a lacy, trabecular or 
sheet-like pattern. In contrast to myositis ossificans 
the bone is usually most prominent in the centre of 
the tumor. 
- Osteoblastic extraskeletal osteosarcoma: the most 
common variant; the tumor cells resemble 
malignant osteoblasts. Bone matrix is abundant. 
- Fibroblastic extraskeletal osteosarcoma: the 
second in frequency; the tumor cell are spindle cells 
arranged in a herringbone or storiform pattern. 
- Chondroid extraskeletal osteosarcoma: malignant 
cartilage predominates in the tumor matrix. 
- Telangiectatic extraskeletal osteosarcoma: it 
contains numerous large blood filled spaces lined 
by malignant cells. 
- Small cell extraskeletal osteosarcoma: the tumor 
cells are arranged in sheets of small round cells that 
mimic Ewing's sarcoma or lymphoma. 
- Well differentiated extraskeletal osteosarcoma: 
rare variant; it contains abundant bone deposited in 
well formed trabeculae, surrounded by a minimally 
atypical spindle cell component similar to parosteal 
osteosarcoma. 
Immunohistochemistry: Several studies indicate 
that the immunophenotype of extraskeletal 
osteosarcoma is similar to osteosarcoma of bone; 
CD99 is expressed in all types of osteosarcoma; 
stain for ALP is positive with a very strong 
reaction; osteocalcin is the most specific antigen for 
extraskeletal osteosarcomas expressed in the 
malignant cells and matrix in 82% and 75% of 
cases, respectively. Extraskeletal osteosarcomas are 
uniformly positive for vimentin, 68% express 
smooth muscle actin, 25% desmin, 20% S100 
protein, 52% EMA, 8% keratin, and 0% PLAP. The 
stain for the Ki-67 analogous MIB-1 shows high 
proliferative activity with values around 25%. 
Differential diagnosis: Myositis ossificans; 
Synovial and epithelioid sarcoma; Extraskeletal 
chondrosarcoma; Malignant fibrous histiocytoma; 
Rhabdomyosarcoma; Hamartoma; Malignant 
schwannoma; Malignant mesenchymoma; 
Liposarcoma with metaplastic bone. 
Cytogenetics 
Systematic genetic differences between 
extraskeletal and bone osteosarcomas have not been 
documented. Three cases with clonal chromosomal 
aberrations have been reported; two tumors showed 
highly complex aberration patterns, whereas the 
third showed a moderately hyperdiploid karyotype 
with relatively few chromosomal abnormalities. 
Treatment 
Wide margin surgical resection is the treatment of 
choice for extraskeletal osteosarcoma. Resection 
can be with amputation of limb salvage surgery if 
microscopically negative margins can be achieved. 
Adjuvant chemotherapy and/or preoperative 
radiation therapy may be useful, although 
extraskeletal osteosarcoma seems relatively 
chemoresistant compared to osseous 
osteosarcomas. Radiation may be delivered by 
external beam, intraoperative, and brachytherapy. 
Given the high grade malignant tumor and poor 
prognosis, aggressive treatment with preoperative 
radiation therapy and surgical resection for local 
tumor control, and (neo-)adjuvant multi-agent 
chemotherapy to improve survival are current 
treatments of choice for the patients with 
extraskeletal osteosarcomas. Aggressive 
thoracotomy and resection of the pulmonary 
metastases may be necessary in patients with lung 
metastases. 
Note: The role of (neo-)adjuvant chemotherapy or 
radiation therapy is controversial. Disease-specific 
clinical trials are required to improve the outcome 
of these patients. 
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Prognosis 
The prognosis of the patients with extraskeletal 
osteosarcoma is poor; the 5-year survival ranges 
from 10% to 46%. More than 50% of the patients 
experience multiple local recurrences and distal 
metastases. Distal metastases are usually to the 
lungs (>80%), followed by the regional lymph 
nodes, bone, brain, liver and skin. 
Note: Reported factors associated with a better 
outcome include size <5 cm (the most important), 
fibroblastic or chondroblastic histological subtype, 
and diminished proliferative activity as measured 
by Ki-67 index. However, the validity of these 
prognostic factors has not been confirmed in large 
studies. The well differentiated variant may behave 
in a more indolent manner; however, too few cases 
have been reported to draw definitive conclusions 
regarding their biologic potential. 
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